Sandbox Turky: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
{{Family tree | | | | | | | | | | | | B01 | | | | B02 | | | | | | | | | | | | B01= Yes|B02=No}} | {{Family tree | | | | | | | | | | | | B01 | | | | B02 | | | | | | | | | | | | B01= Yes|B02=No}} | ||
{{Family tree | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | }} | {{Family tree | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | }} | ||
{{Family tree | | | | | | | | | | | | C01 | | | | C02 | | | | | | | | | | | | C01=Refer to management of [[Acute coronary syndrome resident survival guide|acute coronary syndromes]]|C02=<div style="text-align: | {{Family tree | | | | | | | | | | | | C01 | | | | C02 | | | | | | | | | | | | C01=Refer to management of [[Acute coronary syndrome resident survival guide|acute coronary syndromes]]|C02=<div style="text-align:left; padding:0.7em">Confirm patient has ANY of the following indications for cardiac catheterization | ||
❑ Canadian cardiovascular society (CCS) class III (i.e. symptoms with everyday living activities) or class IV angina (i.e. inability to perform any activity without angina or angina at rest) despite medical therapy, OR | ❑ Canadian cardiovascular society (CCS) class III (i.e. symptoms with everyday living activities) or class IV angina (i.e. inability to perform any activity without angina or angina at rest) despite medical therapy, OR | ||
Line 66: | Line 66: | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }} | {{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }} | ||
{{family tree/end}} | {{family tree/end}} | ||
{{reflist|2}} |
Revision as of 15:14, 17 April 2015
Is cardiac catheterization an emergency? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refer to management of acute coronary syndromes | Confirm patient has ANY of the following indications for cardiac catheterization
❑ Canadian cardiovascular society (CCS) class III (i.e. symptoms with everyday living activities) or class IV angina (i.e. inability to perform any activity without angina or angina at rest) despite medical therapy, OR ❑ Angina plus systolic dysfunction, OR ❑ High-risk stress test finding, defined as ANY of following [1], OR ❑ Resting LVEF < 35% ❑ High-risk treadmill score (≤ 11) ❑ Severe exercise LVEF < 35% ❑ Stress-induced large perfusion defect ❑ Stress-induced multiple perfusion defects ❑ Large, fixed perfusion defect with LV dilation OR increased lung uptake ❑ LV dilation or increased lung uptake ❑ Stress-induced moderate perfusion defect with LV dilation or increased lung uptake ❑ Uncertain diagnosis following non-invasive test and need to confirm diagnosis, OR ❑ Systolic dysfunction with unexplained cause, OR ❑ Survivor of sudden cardiac death, polymorphic VT, or sustained monomorphic VT, OR ❑ Suspected spas m or non-atherosclerotic cause of ischemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ D01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ E01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ F01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ G01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ I01 }}} | {{{ I02 }}} | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ J01-}}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ K01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ L01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ M01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ N01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ O01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- ↑ Marso SP, Teirstein PS, Kereiakes DJ, Moses J, Lasala J, Grantham JA (2012). "Percutaneous coronary intervention use in the United States: defining measures of appropriateness". JACC Cardiovasc Interv. 5 (2): 229–35. doi:10.1016/j.jcin.2011.12.004. PMID 22326193.